Ventana fenestrated stent graft system from Endologix, Inc has received Investigational Device Exemption (IDE) conditional approval from the FDA.

This device is a new aortic extension meant to be used with AFX Endovascular AAA system and Xpand renal stent grafts, manufactured by the same company.
Presently, the Ventana and Xpand stent grafts is allowed only for investigation purposes.
Source-Medindia
MEDINDIA




Email



